Wei Lin — SEC Form 4 filings
SEC reporting owner CIK 1872772. 8 Form 4 filings on record with FilingPulse; latest filed 2026-03-19.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-12 to 2026-03-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 11,995 shares, $600,710 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 5,589 shares @ $37.39 ($208,954) in Revolution Medicines, Inc., filed 2024-06-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Chief Medical Officer | 6 | — | 4 legs · 11,995 sh · $600,710 | 4 |
| 2seventy bio, Inc. (TSVT) | Director | 2 | — | — | 5 |
Form 4 filings — Wei Lin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-19 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 2,073 @ $99.48 | EDGAR |
| 2026-03-03 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 15,100 @ $0 · Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2025-09-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 2,160 @ $45.82 | EDGAR |
| 2025-06-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 2,173 @ $39.83 | EDGAR |
| 2025-05-15 | 4 | 2seventy bio, Inc. (TSVT) | Disposition to issuer (D): 17,583 · Code (U): 15,267 · Disposition to issuer (D): 24,100 (derivative) | EDGAR |
| 2025-03-04 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 20,800 @ $0 · Grant/award (A): 72,800 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 5,589 @ $37.39 | EDGAR |
| 2024-06-12 | 4 | 2seventy bio, Inc. (TSVT) | Grant/award (A): 12,050 @ $0 · Grant/award (A): 24,100 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1872772 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →